This study aims to assess the short-term effects of the FX-class Dialyser on quality of life and inflammatory markers in stable haemodialysis patients with chronic kidney failure.

Official Title

Short-Term Effects of the FX-Class of Haemodialyser on Quality of Life and Inflammatory Markers in Stable Dialysis Patients.


Kidney Failure, Chronic

Study Type


Study Design

Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Efficacy Study.

Further Details

Primary Outcome Measures:

  • KD-QOL
  • Feeling Thermometer

Secondary Outcome Measures:

  • IL-6
  • TNF-alpha
  • hs-CRP
  • white cell count

Study Start

February 2006; Study completion: December 2006

Eligibility & Criteria

  • Ages Eligible for Study: 18 Years and above
  • Genders Eligible for Study: Both

Inclusion criteria:

  • Age >18years
  • Able to provide informed consent
  • On haemodialysis for 3 months

Exclusion criteria

  • Active inflammatory, infective or neoplastic process within the last 1 month
  • Active major psychiatric condition
  • Currently on haemodiafiltration as haemodialysis modality
  • Total Enrolment


    Contact Details

    • Joondalup Health Campus Satellite Renal Dialysis Unit, Shenton Avenue, JOONDALUP, Western Australia, 6050, Australia, Ph:08 9400 9360
    • Sir Charles Gairdner Hospital Renal Dialysis Unit, Hospital Avenue, NEDLANDS, Western Australia, Ph:08 9346 2799